Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Are men with low selenium levels at increased risk of prostate cancer?

Brinkman M, Reulen RC, Kellen E, Buntinx F, Zeegers MP.

Eur J Cancer. 2006 Oct;42(15):2463-71. Epub 2006 Sep 1. Review.

PMID:
16945521
2.

Selenium and prostate cancer: systematic review and meta-analysis.

Hurst R, Hooper L, Norat T, Lau R, Aune D, Greenwood DC, Vieira R, Collings R, Harvey LJ, Sterne JA, Beynon R, Savović J, Fairweather-Tait SJ.

Am J Clin Nutr. 2012 Jul;96(1):111-22. doi: 10.3945/ajcn.111.033373. Epub 2012 May 30. Review.

3.

Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer.

Helzlsouer KJ, Huang HY, Alberg AJ, Hoffman S, Burke A, Norkus EP, Morris JS, Comstock GW.

J Natl Cancer Inst. 2000 Dec 20;92(24):2018-23.

4.

Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk.

Goodman GE, Schaffer S, Bankson DD, Hughes MP, Omenn GS; Carotene and Retinol Efficacy Trial Co-Investigators.

Cancer Epidemiol Biomarkers Prev. 2001 Oct;10(10):1069-76.

5.

Serum selenium and subsequent risk of prostate cancer.

Nomura AM, Lee J, Stemmermann GN, Combs GF Jr.

Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):883-7.

6.

Plasma selenium level before diagnosis and the risk of prostate cancer development.

Brooks JD, Metter EJ, Chan DW, Sokoll LJ, Landis P, Nelson WG, Muller D, Andres R, Carter HB.

J Urol. 2001 Dec;166(6):2034-8.

PMID:
11696701
7.

Selenium levels of patients with newly diagnosed prostate cancer compared with control group.

Lipsky K, Zigeuner R, Zischka M, Schips L, Pummer K, Rehak P, Hubmer G.

Urology. 2004 May;63(5):912-6.

PMID:
15134980
8.

Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis.

Etminan M, FitzGerald JM, Gleave M, Chambers K.

Cancer Causes Control. 2005 Nov;16(9):1125-31.

PMID:
16184479
9.

A case-control study of toenail selenium and cancer of the breast, colon, and prostate.

Ghadirian P, Maisonneuve P, Perret C, Kennedy G, Boyle P, Krewski D, Lacroix A.

Cancer Detect Prev. 2000;24(4):305-13.

PMID:
11059562
10.

Predictors of toenail selenium levels in men and women.

van den Brandt PA, Goldbohm RA, van't Veer P, Bode P, Hermus RJ, Sturmans F.

Cancer Epidemiol Biomarkers Prev. 1993 Mar-Apr;2(2):107-12.

11.

A meta-analysis of diabetes mellitus and the risk of prostate cancer.

Kasper JS, Giovannucci E.

Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2056-62.

12.

Levels of selenium in plasma and glutathione peroxidase in erythrocytes in patients with prostate cancer or benign hyperplasia.

Hardell L, Degerman A, Tomic R, Marklund SL, Bergfors M.

Eur J Cancer Prev. 1995 Feb;4(1):91-5.

PMID:
7537140
13.

Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH.

Muecke R, Klotz T, Giedl J, Buentzel J, Kundt G, Kisters K, Prott FJ, Micke O.

Acta Oncol. 2009;48(3):452-6. doi: 10.1080/02841860802403721.

PMID:
18855158
14.

[Vasectomy not associated with prostate cancer: a meta-analysis].

Tang LF, Jiang H, Shang XJ, Zhao LM, Bai Q, Hong K, Liu DF, Liu JM, Yuan RP, Chen Q, Ma LL.

Zhonghua Nan Ke Xue. 2009 Jun;15(6):545-50. Chinese.

PMID:
19593998
15.

Advanced prostate cancer risk in relation to toenail selenium levels.

Geybels MS, Verhage BA, van Schooten FJ, Goldbohm RA, van den Brandt PA.

J Natl Cancer Inst. 2013 Sep 18;105(18):1394-401. doi: 10.1093/jnci/djt186. Epub 2013 Jul 22.

16.

[Relation between selenium plasma levels and different prostatic pathologies].

López Fontana CM, Pérez Elizalde RF, Vanrell MC, Recalde GM, Uvilla AL, López Laur JD.

Actas Urol Esp. 2010 Jul;34(7):625-9. Spanish.

PMID:
20540880
17.
18.

Prostatic and peripheral blood selenium levels after oral supplementation.

Gianduzzo TR, Holmes EG, Tinggi U, Shahin M, Mactaggart P, Nicol D.

J Urol. 2003 Sep;170(3):870-3.

PMID:
12913719
19.

Depressed serum selenoprotein P: possible new predicator of increased risk for cerebrovascular events.

Koyama H, Abdulah R, Ohkubo T, Imai Y, Satoh H, Nagai K.

Nutr Res. 2009 Feb;29(2):94-9. doi: 10.1016/j.nutres.2009.01.002.

PMID:
19285599
20.

Case-control study of toenail cadmium and prostate cancer risk in Italy.

Vinceti M, Venturelli M, Sighinolfi C, Trerotoli P, Bonvicini F, Ferrari A, Bianchi G, Serio G, Bergomi M, Vivoli G.

Sci Total Environ. 2007 Feb 1;373(1):77-81. Epub 2006 Dec 15.

PMID:
17175009
Items per page

Supplemental Content

Write to the Help Desk